newsfilter
← Latest News
GlobeNewswire·

BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the